AIkido Pharma (NASDAQ:AIKI) Stock Rating Lowered by Zacks Investment Research

AIkido Pharma (NASDAQ:AIKI – Get Rating) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research report issued on Friday, Zacks.com reports. According to Zacks, “AIkido Pharma Inc. is a biotechnology development company with a diverse portfolio of early stage small-molecule anti-cancer therapeutics. The company’s pipeline of therapeutics […]

Related Keywords

New York ,United States , ,Equitec Proprietary Markets ,Aikido Pharma Company Profile Get Rating ,Geode Capital Management ,Zacks Investment Research ,Aikido Pharma Inc ,Renaissance Technologies ,Spherix Incorporated ,Citadel Advisors ,Get Rating ,Pharma Inc ,Capital Management ,Proprietary Markets ,Street Group ,Pharma Company Profile ,Aikido Pharma ,Nasdaq Aiki ,Taiki ,Medical ,Downgrade ,